| Budget Amount *help |
¥24,310,000 (Direct Cost: ¥18,700,000、Indirect Cost: ¥5,610,000)
Fiscal Year 2019: ¥7,020,000 (Direct Cost: ¥5,400,000、Indirect Cost: ¥1,620,000)
Fiscal Year 2018: ¥7,800,000 (Direct Cost: ¥6,000,000、Indirect Cost: ¥1,800,000)
Fiscal Year 2017: ¥9,490,000 (Direct Cost: ¥7,300,000、Indirect Cost: ¥2,190,000)
|
|---|
| Outline of Final Research Achievements |
The purpose of this study is to develop an efficient method to produce subtype specific cardiomyocytes from human iPSCs via metabolic regulation for regenerative medicine and drug discovery. In this project, we identified optimal culture conditions for human iPSCs expansion (1). In addition, we also developed an efficient method to produce subtype specific cardiomyocytes from human iPSCs (2). Moreover, we evaluated metabolic profiles in subtype specific cardiomyocytes via multi-omics (3). These findings will eventually promote the clinical applications of regenerative medicine and drug discovery.
|
